Effect of Topical Lidocaine on Warm and Cold Sensation in Healthy Individuals
NCT ID: NCT04865185
Last Updated: 2021-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2021-03-01
2022-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lidocaine and Neuroma Pain Related Modalities
NCT02300038
The Effect of Intravenous Lidocaine on Normal Sensation and Pain in Healthy Volunteers
NCT00657358
Safety of Intravenous Lidocaine Infusions
NCT01091935
Effect of Systemic Ropivacaine on Hyperalgesia, Flare Reaction and Peripheral Nerve Excitability
NCT00900913
Vapocoolant Spray for Reducing the Pain of Spinal Needle Insertion
NCT03175913
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Alterations in thermal perception can results in paradoxical heat sensation (a warm perception when the skin is cooled) or a peculiar/burning sensation when the skin is stiumlated with simultaneous warm and cold (a "thermal grill").
Clarifying the occurrence of these paradoxical and illusory sensations, may help understanding early signs of peripheral neuropathy as well as thermal sensory perception.
The investigators plan to conduct a study on thermal sensory perception using a model of sensory loss in healthy volunteers and systematically test the occurrence of paradoxical heat sensations and responses to the thermal grill.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Xylocaine spray 100mg/ml
Topical application
Xylocaine spray 100mg/ml
Topical application
Ethanol
Topical application
Ethanol
Topical application
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Xylocaine spray 100mg/ml
Topical application
Ethanol
Topical application
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18 and 40 years
* Participant is able and willing to give informed consent.
Exclusion Criteria
* Non-cooperative
* Chronic pain or acute pain the past week lasting more than 4 hours or pain on the day of investigation
* Pain medication within the last week
* Medication within the last week that can affect assessment
* Psychiatric or neurological disease and diseases that may affect the assessment
* Sensory disturbances
* History or symptoms of significant diseases (e.g. psychiatric or neurological disease, diseases that may affect the assessment, sensory disturbances, cancer, diabetes mellitus, liver diseases, kidney diseases, cardiovascular diseases)
* Pregnancy or lactation
* Jetlag or sleep deprivation
* Alcohol or drug abuse
* Consumption of cannabis the last 4 weeks and consumption of alcohol in the last 48 hours
* Any abnormality of the skin or of vascular origin at application site
* History of hypersensitivity to lidocaine, other amide-type anesthetics, or other contents of the lidocaine or vehicle
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ellen L Schaldemose, MD
Role: PRINCIPAL_INVESTIGATOR
Danish Pain Research Center, Aarhus University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Danish Pain Research Center, Aarhus University, Aarhus University Hospital
Aarhus N, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TLH21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.